>
Sumitomo Dainippon Pharma Co logo

4506 - Sumitomo Dainippon Pharma Co Share Price

¥1878 -11.0  -0.6%

Last Trade - 6:10am

Sector
Healthcare
Size
Large Cap
Market Cap £4.91bn
Enterprise Value £5.93bn
Revenue £3.36bn
Position in Universe 194th / 3912
Bullish
Bearish
Unlock 4506 Revenue
Momentum
Relative Strength (%)
1m -14.4%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -20.1%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2016 2017 2018 2019 2020 2021 2022E 2023E CAGR / Avg
403,206 408,357 466,838 459,267 482,732 515,952 579,599 585,159 +5.1%
+97.1 +39.8 +19.1 -11.4 -25.5 +56.0 -6.50 -1.53
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the three months ended 30 June 2021, SumitomoDainippon Pharma Co Ltd revenues decreased 2% to Y131.2B.Net income decreased 74% to Y4.8B. Revenues reflect adecrease in demand for the Company's products and servicesdue to unfavorable market conditions. Net income alsoreflects Total SG&A Expense increase of 27% to Y62.06B(expense), Other Operating Expense increase of 43% to Y278M(expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

4506 Revenue Unlock 4506 Revenue

Net Income

4506 Net Income Unlock 4506 Revenue

Normalised EPS

4506 Normalised EPS Unlock 4506 Revenue

PE Ratio Range

4506 PE Ratio Range Unlock 4506 Revenue

Dividend Yield Range

4506 Dividend Yield Range Unlock 4506 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
4506 EPS Forecasts Unlock 4506 Revenue
Profile Summary

Sumitomo Dainippon Pharma Co., Ltd., is a pharmaceutical company. The Company operates in four segments. The Japan segment manufactures and sells medical drugs. The North America segment manufactures, develops, purchases and sells ethical drugs. The China segment manufactures and sells ethical drugs through its consolidated subsidiary. The Other Overseas division is involved in the development of its products in Europe. The Company is also engaged in the manufacture, purchase, sale and supply of food materials and additives, chemical products, veterinary drugs, diagnostic products and inspection services of clinical pathology for animal, the manufacture of extracts, as well as the storage, delivery and clinical inspection of drugs.

Directors
Last Annual March 31st, 2021
Last Interim June 30th, 2021
Incorporated May 14, 1897
Public Since May 16, 1949
No. of Shareholders: 22,445
No. of Employees: 6,822
Sector Healthcare
Industry Pharmaceuticals
Index Nikkei 225 ,
Exchange Tokyo Stock Exchange
Shares in Issue 397,293,585
Free Float (0.0%)
Eligible for
ISAs
SIPPs
4506 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 4506
Upcoming Events for 4506
Wednesday 29th September, 2021
Dividend For 4506.T - 14.0000 JPY
Tuesday 26th October, 2021 Estimate
Q2 2022 Sumitomo Dainippon Pharma Co Ltd Earnings Release
Wednesday 26th January, 2022 Estimate
Q3 2022 Sumitomo Dainippon Pharma Co Ltd Earnings Release
Frequently Asked Questions for Sumitomo Dainippon Pharma Co
What is the Sumitomo Dainippon Pharma Co share price?

As of 6:10am, shares in Sumitomo Dainippon Pharma Co are trading at ¥1878, giving the company a market capitalisation of £4.91bn. This share price information is delayed by 15 minutes.

How has the Sumitomo Dainippon Pharma Co share price performed this year?

Shares in Sumitomo Dainippon Pharma Co are currently trading at ¥1878 and the price has moved by 42.24% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Sumitomo Dainippon Pharma Co price has moved by 16.47% over the past year.

What are the analyst and broker recommendations for Sumitomo Dainippon Pharma Co?

Of the analysts with advisory recommendations for Sumitomo Dainippon Pharma Co, there are there are currently 1 "buy" , 3 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Sumitomo Dainippon Pharma Co is Sell. You can view the full broker recommendation list by unlocking its StockReport.

When will Sumitomo Dainippon Pharma Co next release its financial results?

Sumitomo Dainippon Pharma Co is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-06-30
What is the Sumitomo Dainippon Pharma Co dividend yield?

The Sumitomo Dainippon Pharma Co dividend yield is 1.48% based on the trailing twelve month period.

Does Sumitomo Dainippon Pharma Co pay a dividend?

Last year, Sumitomo Dainippon Pharma Co paid a total dividend of 28, and it currently has a trailing dividend yield of 1.48%. Looking ahead, shares in Sumitomo Dainippon Pharma Co are due to go ex-dividend on 2021-09-29 and the next dividend pay date is 2021-12-01.

When does Sumitomo Dainippon Pharma Co next pay dividends?

Sumitomo Dainippon Pharma Co are due to go ex-dividend on 2021-09-29 and the next dividend pay date is 2021-12-01. The historic dividend yield on Sumitomo Dainippon Pharma Co shares is currently 1.48%.

How do I buy Sumitomo Dainippon Pharma Co shares?

To buy shares in Sumitomo Dainippon Pharma Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Sumitomo Dainippon Pharma Co?

Shares in Sumitomo Dainippon Pharma Co are currently trading at ¥1878, giving the company a market capitalisation of £4.91bn.

Where are Sumitomo Dainippon Pharma Co shares listed? Where are Sumitomo Dainippon Pharma Co shares listed?

Here are the trading details for Sumitomo Dainippon Pharma Co:

Country of listing: Japan
Exchange: TYO
Ticker Symbol: 4506
What kind of share is Sumitomo Dainippon Pharma Co?

Based on an overall assessment of its quality, value and momentum, Sumitomo Dainippon Pharma Co is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Sumitomo Dainippon Pharma Co share price forecast 2021?

Shares in Sumitomo Dainippon Pharma Co are currently priced at ¥1878. At that level they are trading at 1.18% premium to the analyst consensus target price of 0.00.

Analysts covering Sumitomo Dainippon Pharma Co currently have a consensus Earnings Per Share (EPS) forecast of 128.229 for the next financial year.

How can I tell whether the Sumitomo Dainippon Pharma Co share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sumitomo Dainippon Pharma Co. Over the past six months, the relative strength of its shares against the market has been 14.61%. At the current price of ¥1878, shares in Sumitomo Dainippon Pharma Co are trading at 6.85% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Sumitomo Dainippon Pharma Co PE Ratio?

The Sumitomo Dainippon Pharma Co PE ratio based on its reported earnings over the past 12 months is 17.56. The shares are currently trading at ¥1878.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Sumitomo Dainippon Pharma Co?

Sumitomo Dainippon Pharma Co's management team is headed by:

Masayo Tada - CHM
Hiroshi Nomura - PRE
Yoshiharu Ikeda - MEO
Hitoshi Odagiri - SME
Hiroyuki Baba - MEO
Toru Kimura - CSO
Shigeyuki Nishinaka - MEO
Hideyuki Harada - MEO
Patricia Andrews - EXO
Yutaka Atomi - IND
Saeko Arai - IND
Nobuhiro Endo - IND
Takuya Taguchi - DSL
Minoru Usui - IND
Who are the major shareholders of Sumitomo Dainippon Pharma Co?

Here are the top five shareholders of Sumitomo Dainippon Pharma Co based on the size of their shareholding:

Sumitomo Chemical Co Ltd Corporation
Percentage owned: 51.68% (205.6m shares)
Inabata & Co Ltd Corporation
Percentage owned: 4.19% (16.7m shares)
Nomura Asset Management Co., Ltd. Investment Advisor
Percentage owned: 3.78% (15.0m shares)
Nomura NEXT FUNDS Nikkei 225 Exchange Traded Fund Mutual Fund
Percentage owned: 2.53% (10.0m shares)
Nippon Life Insurance Company Insurance Company
Percentage owned: 1.91% (7.58m shares)
Similar to 4506
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.